Advertisement
UK markets close in 8 hours 11 minutes
  • FTSE 100

    8,068.20
    +27.82 (+0.35%)
     
  • FTSE 250

    19,620.81
    -98.56 (-0.50%)
     
  • AIM

    754.95
    +0.26 (+0.03%)
     
  • GBP/EUR

    1.1660
    +0.0015 (+0.13%)
     
  • GBP/USD

    1.2493
    +0.0031 (+0.24%)
     
  • Bitcoin GBP

    51,525.16
    -1,972.62 (-3.69%)
     
  • CMC Crypto 200

    1,390.77
    +8.19 (+0.59%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    83.05
    +0.24 (+0.29%)
     
  • GOLD FUTURES

    2,333.50
    -4.90 (-0.21%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,293.61
    +92.34 (+0.54%)
     
  • DAX

    18,036.46
    -52.24 (-0.29%)
     
  • CAC 40

    8,094.28
    +2.42 (+0.03%)
     

Why Dynavax Crushed the Market on Thursday

Biotech Dynavax Technologies (NASDAQ: DVAX) had a terrific Thursday on the stock market. Thursday morning, Valneva announced that the committee for medicinal products for human use (CHMP) advising the European Medicines Agency (EMA) has recommended the jab be granted marketing authorization as a primary shot for adults 18 to 50 years old. The next step is for the European Commission (EC) to review the CHMP's recommendation and make a decision.